{"id":{"repo_id":"uiuc","oai_identifier":"oai:www.ideals.illinois.edu:2142/108080"},"canonical_url":"https://search.dev.ndltd.org/etd/uiuc/oai:www.ideals.illinois.edu:2142/108080","repository":{"repo_id":"uiuc","name":"University of Illinois - Urbana-Champaign","base_url":"https://www.ideals.illinois.edu/oai-pmh"},"display":{"title":"Adapting a gelatin hydrogel platform to investigate glioblastoma progression","abstract":"According to the World of Health Organization, cancer is the leading cause of death worldwide, responsible for approximately 1 in 6 deaths globally. In the United States alone, there are approximately 80,000 new cases of primary brain tumors diagnosed annually, with a third of those being malignant brain cancer. Glioblastoma is the most common and lethal form of adult brain cancer, contribute to about 13,000 new cases annually in the U.S. Despite current clinical standard-of-care, which involves surgical tumor debulking followed by chemotherapy and radiotherapy, patient prognosis remains poor (median survival ~15 months; 5+ year survival <5-15%) and has not significantly improved for decades. Poor survival is linked to the rapid, diffuse infiltration of GBM throughout the brain and the inability to surgically resect or therapeutically target these diffusely spread cells. While significant insight has been gained to how structural or mechanical features of the tumor microenvironment may influence GBM invasion, it is unclear how cohorts of diverse cells that exist within the tumor microenvironment shape GBM invasion and drug resistance. This dissertation describes a bioengineering approach to develop biomaterial models of the GBM tumor microenvironment to study how structural (stiffness, hyaluronan content) and metabolic (e.g., hypoxia) gradients within the tumor margin, as well as the heterogenous cellular make-up of the GBM tumor shape its progression. We fabricated brain mimetic hydrogels matching biophysical features of the tumor and margins, designed culture conditions mimicking tumor hypoxia and activation of microglia immune cells from the GBM tumor microenvironment. Together, we showed that the combined influence of transitions in biophysical and biochemical composition as well as the immune cells greatly influence on GBM invasion, bringing new insight to potential therapeutic interventions to better target this disease.","abstract_html":"According to the World of Health Organization, cancer is the leading cause of death worldwide, responsible for approximately 1 in 6 deaths globally. In the United States alone, there are approximately 80,000 new cases of primary brain tumors diagnosed annually, with a third of those being malignant brain cancer. Glioblastoma is the most common and lethal form of adult brain cancer, contribute to about 13,000 new cases annually in the U.S. Despite current clinical standard-of-care, which involves surgical tumor debulking followed by chemotherapy and radiotherapy, patient prognosis remains poor (median survival ~15 months; 5+ year survival &lt;5-15%) and has not significantly improved for decades. Poor survival is linked to the rapid, diffuse infiltration of GBM throughout the brain and the inability to surgically resect or therapeutically target these diffusely spread cells. While significant insight has been gained to how structural or mechanical features of the tumor microenvironment may influence GBM invasion, it is unclear how cohorts of diverse cells that exist within the tumor microenvironment shape GBM invasion and drug resistance. This dissertation describes a bioengineering approach to develop biomaterial models of the GBM tumor microenvironment to study how structural (stiffness, hyaluronan content) and metabolic (e.g., hypoxia) gradients within the tumor margin, as well as the heterogenous cellular make-up of the GBM tumor shape its progression. We fabricated brain mimetic hydrogels matching biophysical features of the tumor and margins, designed culture conditions mimicking tumor hypoxia and activation of microglia immune cells from the GBM tumor microenvironment. Together, we showed that the combined influence of transitions in biophysical and biochemical composition as well as the immune cells greatly influence on GBM invasion, bringing new insight to potential therapeutic interventions to better target this disease.","abstract_has_math":false,"creators":["Chen, Jee-Wei Emily"],"institution":"University of Illinois at Urbana-Champaign","degree_name":"Ph.D.","degree_level":"Dissertation","degree_discipline":"Chemical Engineering","degree_department":null,"school":null,"contributors":["Harley, Brendan","Kraft, Mary","Gaskins, H Rex","Kong, Hyun Joon"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2020,"date_issued":"2020-08-26T23:51:20Z","date_published":"2020-08-26T23:51:20Z","updated_at":"2026-07-22T22:24:47Z","subjects":["glioblastoma","biomaterials"],"languages":["en"],"rights":["Copyright 2020 Jee-Wei Chen"],"rights_urls":[],"identifier_entries":[]},"links":{"outbound_url":"http://hdl.handle.net/2142/108080","outbound_label":"Handle","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Harley, Brendan","Kraft, Mary","Gaskins, H Rex","Kong, Hyun Joon"]},{"key":"dc:creator","label":"Author","values":["Chen, Jee-Wei Emily"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2020-08-26T23:51:20Z","2022-08-26T23:58:55Z","2020-01-17","2020-05"]},{"key":"dc:type","label":"Dc Type","values":["text","Thesis"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Chemical Engineering"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Dissertation"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Ph.D."]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["University of Illinois at Urbana-Champaign"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["glioblastoma","biomaterials"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["en"]},{"key":"dc:rights","label":"Dc Rights","values":["Copyright 2020 Jee-Wei Chen"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["http://hdl.handle.net/2142/108080"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["According to the World of Health Organization, cancer is the leading cause of death worldwide, responsible for approximately 1 in 6 deaths globally. In the United States alone, there are approximately 80,000 new cases of primary brain tumors diagnosed annually, with a third of those being malignant brain cancer. Glioblastoma is the most common and lethal form of adult brain cancer, contribute to about 13,000 new cases annually in the U.S. Despite current clinical standard-of-care, which involves surgical tumor debulking followed by chemotherapy and radiotherapy, patient prognosis remains poor (median survival ~15 months; 5+ year survival <5-15%) and has not significantly improved for decades. Poor survival is linked to the rapid, diffuse infiltration of GBM throughout the brain and the inability to surgically resect or therapeutically target these diffusely spread cells. While significant insight has been gained to how structural or mechanical features of the tumor microenvironment may influence GBM invasion, it is unclear how cohorts of diverse cells that exist within the tumor microenvironment shape GBM invasion and drug resistance. This dissertation describes a bioengineering approach to develop biomaterial models of the GBM tumor microenvironment to study how structural (stiffness, hyaluronan content) and metabolic (e.g., hypoxia) gradients within the tumor margin, as well as the heterogenous cellular make-up of the GBM tumor shape its progression. We fabricated brain mimetic hydrogels matching biophysical features of the tumor and margins, designed culture conditions mimicking tumor hypoxia and activation of microglia immune cells from the GBM tumor microenvironment. Together, we showed that the combined influence of transitions in biophysical and biochemical composition as well as the immune cells greatly influence on GBM invasion, bringing new insight to potential therapeutic interventions to better target this disease.","Submission published under a 24 month embargo labeled 'U of I Access', the embargo will last until 2022-05-01","The student, Jee-Wei Chen, accepted the attached license on 2020-01-14 at 07:08.","The student, Jee-Wei Chen, submitted this Dissertation for approval on 2020-01-14 at 07:39.","This Dissertation was approved for publication on 2020-01-17 at 16:50.","DSpace SAF Submission Ingestion Package generated from Vireo submission #14845 on 2020-08-25 at 17:26:23","Made available in DSpace on 2020-08-26T23:51:20Z (GMT). No. of bitstreams: 2 CHEN-DISSERTATION-2020.pdf: 8227360 bytes, checksum: 4ffd7d6d15e7f385510d7c7dfdf1b1a0 (MD5) LICENSE.txt: 4209 bytes, checksum: 212f72413bf4ab005cfa94a14420ba46 (MD5) Previous issue date: 2020-01-17","Embargo set by: Seth Robbins for item 115689 Lift date: 2022-08-26T23:51:32Z Reason: Author requested U of Illinois access only (OA after 2yrs) in Vireo ETD system","Embargo set by: Seth Robbins for item 115689 Lift date: 2022-08-26T23:54:40Z Reason: Author requested U of Illinois access only (OA after 2yrs) in Vireo ETD system","Embargo set by: Seth Robbins for item 115689 Lift date: 2022-08-26T23:55:59Z Reason: Author requested U of Illinois access only (OA after 2yrs) in Vireo ETD system","Embargo set by: Seth Robbins for item 115689 Lift date: 2022-08-26T23:57:28Z Reason: Author requested U of Illinois access only (OA after 2yrs) in Vireo ETD system","Embargo set by: Seth Robbins for item 115689 Lift date: 2022-08-26T23:58:55Z Reason: Author requested U of Illinois access only (OA after 2yrs) in Vireo ETD system","Author requested U of Illinois access only (OA after 2yrs) in Vireo ETD system","U of I Only"]},{"key":"dc:format","label":"Dc Format","values":["application/pdf"]},{"key":"dc:title","label":"Title","values":["Adapting a gelatin hydrogel platform to investigate glioblastoma progression"]}]}],"canonical_facts":{"dc:contributor":["Harley, Brendan","Kraft, Mary","Gaskins, H Rex","Kong, Hyun Joon"],"dc:creator":["Chen, Jee-Wei Emily"],"dc:date":["2020-08-26T23:51:20Z","2022-08-26T23:58:55Z","2020-01-17","2020-05"],"dc:description":["According to the World of Health Organization, cancer is the leading cause of death worldwide, responsible for approximately 1 in 6 deaths globally. In the United States alone, there are approximately 80,000 new cases of primary brain tumors diagnosed annually, with a third of those being malignant brain cancer. Glioblastoma is the most common and lethal form of adult brain cancer, contribute to about 13,000 new cases annually in the U.S. Despite current clinical standard-of-care, which involves surgical tumor debulking followed by chemotherapy and radiotherapy, patient prognosis remains poor (median survival ~15 months; 5+ year survival <5-15%) and has not significantly improved for decades. Poor survival is linked to the rapid, diffuse infiltration of GBM throughout the brain and the inability to surgically resect or therapeutically target these diffusely spread cells. While significant insight has been gained to how structural or mechanical features of the tumor microenvironment may influence GBM invasion, it is unclear how cohorts of diverse cells that exist within the tumor microenvironment shape GBM invasion and drug resistance. This dissertation describes a bioengineering approach to develop biomaterial models of the GBM tumor microenvironment to study how structural (stiffness, hyaluronan content) and metabolic (e.g., hypoxia) gradients within the tumor margin, as well as the heterogenous cellular make-up of the GBM tumor shape its progression. We fabricated brain mimetic hydrogels matching biophysical features of the tumor and margins, designed culture conditions mimicking tumor hypoxia and activation of microglia immune cells from the GBM tumor microenvironment. Together, we showed that the combined influence of transitions in biophysical and biochemical composition as well as the immune cells greatly influence on GBM invasion, bringing new insight to potential therapeutic interventions to better target this disease.","Submission published under a 24 month embargo labeled 'U of I Access', the embargo will last until 2022-05-01","The student, Jee-Wei Chen, accepted the attached license on 2020-01-14 at 07:08.","The student, Jee-Wei Chen, submitted this Dissertation for approval on 2020-01-14 at 07:39.","This Dissertation was approved for publication on 2020-01-17 at 16:50.","DSpace SAF Submission Ingestion Package generated from Vireo submission #14845 on 2020-08-25 at 17:26:23","Made available in DSpace on 2020-08-26T23:51:20Z (GMT). No. of bitstreams: 2 CHEN-DISSERTATION-2020.pdf: 8227360 bytes, checksum: 4ffd7d6d15e7f385510d7c7dfdf1b1a0 (MD5) LICENSE.txt: 4209 bytes, checksum: 212f72413bf4ab005cfa94a14420ba46 (MD5) Previous issue date: 2020-01-17","Embargo set by: Seth Robbins for item 115689 Lift date: 2022-08-26T23:51:32Z Reason: Author requested U of Illinois access only (OA after 2yrs) in Vireo ETD system","Embargo set by: Seth Robbins for item 115689 Lift date: 2022-08-26T23:54:40Z Reason: Author requested U of Illinois access only (OA after 2yrs) in Vireo ETD system","Embargo set by: Seth Robbins for item 115689 Lift date: 2022-08-26T23:55:59Z Reason: Author requested U of Illinois access only (OA after 2yrs) in Vireo ETD system","Embargo set by: Seth Robbins for item 115689 Lift date: 2022-08-26T23:57:28Z Reason: Author requested U of Illinois access only (OA after 2yrs) in Vireo ETD system","Embargo set by: Seth Robbins for item 115689 Lift date: 2022-08-26T23:58:55Z Reason: Author requested U of Illinois access only (OA after 2yrs) in Vireo ETD system","Author requested U of Illinois access only (OA after 2yrs) in Vireo ETD system","U of I Only"],"dc:format":["application/pdf"],"dc:identifier":["http://hdl.handle.net/2142/108080"],"dc:language":["en"],"dc:rights":["Copyright 2020 Jee-Wei Chen"],"dc:subject":["glioblastoma","biomaterials"],"dc:title":["Adapting a gelatin hydrogel platform to investigate glioblastoma progression"],"dc:type":["text","Thesis"],"thesis:degree_discipline":["Chemical Engineering"],"thesis:degree_level":["Dissertation"],"thesis:degree_name":["Ph.D."],"thesis:institution_name":["University of Illinois at Urbana-Champaign"]},"updated_at":"2026-07-22T22:24:47Z"}